Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 2
1975 1
1978 1
1979 1
1980 1
1981 1
1982 1
1983 2
1984 1
1985 1
1986 3
1987 2
1988 6
1989 2
1990 5
1991 5
1992 3
1993 2
1994 3
1995 1
1996 8
1997 4
1998 2
1999 1
2000 5
2001 1
2002 3
2003 3
2004 9
2005 5
2006 6
2007 4
2008 2
2009 5
2010 7
2011 2
2012 1
2013 4
2014 2
2015 5
2016 3
2017 7
2018 4
2019 6
2020 95
2021 223
2022 274
2023 215
2024 63

Text availability

Article attribute

Article type

Publication date

Search Results

874 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Recurrent viral pneumonia"
Page 1
Respiratory syncytial virus, recurrent wheeze and asthma: A narrative review of pathophysiology, prevention and future directions.
Binns E, Tuckerman J, Licciardi PV, Wurzel D. Binns E, et al. J Paediatr Child Health. 2022 Oct;58(10):1741-1746. doi: 10.1111/jpc.16197. Epub 2022 Sep 8. J Paediatr Child Health. 2022. PMID: 36073299 Free PMC article. Review.
Globally, respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and pneumonia in young children, and the association between severe RSV disease and later recurrent wheeze and asthma is well established. ...In this review, we summarise current under …
Globally, respiratory syncytial virus (RSV) is the leading cause of bronchiolitis and pneumonia in young children, and the associatio …
COVID-19 vaccines adverse events: potential molecular mechanisms.
Lamprinou M, Sachinidis A, Stamoula E, Vavilis T, Papazisis G. Lamprinou M, et al. Immunol Res. 2023 Jun;71(3):356-372. doi: 10.1007/s12026-023-09357-5. Epub 2023 Jan 6. Immunol Res. 2023. PMID: 36607502 Free PMC article. Review.
However, despite the benefits of COVID-19 vaccination, some rare adverse effects have been reported and have been associated with the use of the vaccines developed against SARS-CoV-2, especially those based on mRNA and non-replicating viral vector technology. Rare adverse …
However, despite the benefits of COVID-19 vaccination, some rare adverse effects have been reported and have been associated with the use of …
Nirmatrelvir and COVID-19: development, pharmacokinetics, clinical efficacy, resistance, relapse, and pharmacoeconomics.
Focosi D, McConnell S, Shoham S, Casadevall A, Maggi F, Antonelli G. Focosi D, et al. Int J Antimicrob Agents. 2023 Feb;61(2):106708. doi: 10.1016/j.ijantimicag.2022.106708. Epub 2023 Jan 2. Int J Antimicrob Agents. 2023. PMID: 36603694 Free PMC article. Review.
The preclinical development, pharmacodynamics and pharmacokinetics of N/R are reviewed herein. Randomized clinical trials have been conducted exclusively with pre-Omicron variants of concern, but in vitro studies show that efficacy against all Omicron sublineages is …
The preclinical development, pharmacodynamics and pharmacokinetics of N/R are reviewed herein. Randomized clinical trials have …
Triple Combination Therapy With 2 Antivirals and Monoclonal Antibodies for Persistent or Relapsed Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Patients.
Mikulska M, Sepulcri C, Dentone C, Magne F, Balletto E, Baldi F, Labate L, Russo C, Mirabella M, Magnasco L, Di Grazia C, Ghiggi C, Raiola AM, Giacobbe DR, Vena A, Beltramini S, Bruzzone B, Lemoli RM, Angelucci E, Bassetti M. Mikulska M, et al. Clin Infect Dis. 2023 Jul 26;77(2):280-286. doi: 10.1093/cid/ciad181. Clin Infect Dis. 2023. PMID: 36976301
The main outcomes were virological response at day 14 (negative Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] swab) and virological and clinical response (alive, asymptomatic, with negative SARS-CoV-2 swab) at day 30 and the last follow-up. ...CONCLUSIONS: C …
The main outcomes were virological response at day 14 (negative Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2] swab) and virol …
Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression.
Bobrovitz N, Ware H, Ma X, Li Z, Hosseini R, Cao C, Selemon A, Whelan M, Premji Z, Issa H, Cheng B, Abu Raddad LJ, Buckeridge DL, Van Kerkhove MD, Piechotta V, Higdon MM, Wilder-Smith A, Bergeri I, Feikin DR, Arora RK, Patel MK, Subissi L. Bobrovitz N, et al. Lancet Infect Dis. 2023 May;23(5):556-567. doi: 10.1016/S1473-3099(22)00801-5. Epub 2023 Jan 18. Lancet Infect Dis. 2023. PMID: 36681084 Free PMC article.
The main outcomes were the protective effectiveness against reinfection and against hospital admission or severe disease of hybrid immunity, hybrid immunity relative to previous infection alone, hybrid immunity relative to previous vaccination alone, and hybrid immunity relative …
The main outcomes were the protective effectiveness against reinfection and against hospital admission or severe disease of hybrid immunity, …
GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial.
Zhang M, Wei G, Zhou L, Zhou J, Chen S, Zhang W, Wang D, Luo X, Cui J, Huang S, Fu S, Zhou X, Tang Y, Ding X, Kuang J, He XP, Hu Y, Huang H. Zhang M, et al. Lancet Haematol. 2023 Feb;10(2):e107-e116. doi: 10.1016/S2352-3026(22)00372-6. Lancet Haematol. 2023. PMID: 36725117 Clinical Trial.
METHODS: POLARIS was a first-in-human, single-centre, single-arm, phase 1 trial of GPRC5D-targeted CAR T cells (OriCAR-017) done at the First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. ...Safety and activity analyses included all patien …
METHODS: POLARIS was a first-in-human, single-centre, single-arm, phase 1 trial of GPRC5D-targeted CAR T cells (OriCAR-017) done at t …
Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry.
Bikdeli B, Caraballo C, Trujillo-Santos J, Galanaud JP, di Micco P, Rosa V, Cusidó GV, Schellong S, Mellado M, Del Valle Morales M, Gavín-Sebastián O, Mazzolai L, Krumholz HM, Monreal M; RIETE Investigators. Bikdeli B, et al. JAMA Cardiol. 2022 Aug 1;7(8):857-865. doi: 10.1001/jamacardio.2022.1988. JAMA Cardiol. 2022. PMID: 35830171 Free PMC article.
OBJECTIVE: To determine the clinical characteristics, short-term, and 1-year outcomes in patients with IDDVT and to compare the outcomes in unadjusted and multivariable adjusted analyses with patients who had proximal DVT. ...Such differences were likely multifactorial, in …
OBJECTIVE: To determine the clinical characteristics, short-term, and 1-year outcomes in patients with IDDVT and to compare the outco …
Vaccines and Disease Relapses in Children with Nephrotic Syndrome.
Angeletti A, Bruschi M, Bianchin S, Bonato I, Montobbio C, Verrina E, Lugani F, Cravedi P, Ghiggeri GM. Angeletti A, et al. Clin J Am Soc Nephrol. 2021 Jun;16(6):937-938. doi: 10.2215/CJN.01890221. Epub 2021 Jun 11. Clin J Am Soc Nephrol. 2021. PMID: 34117084 Free PMC article. Clinical Trial. No abstract available.
MS, pregnancy and COVID-19.
Yam C, Jokubaitis V, Hellwig K, Dobson R. Yam C, et al. Mult Scler. 2020 Sep;26(10):1137-1146. doi: 10.1177/1352458520949152. Epub 2020 Aug 17. Mult Scler. 2020. PMID: 32924838 Free PMC article. Review.
There is currently a relative paucity of information to guide advice given to and the clinical management of these individuals. Much of the limited available data around COVID-19 and pregnancy derives from the obstetric literature, and as such, neurologists may not be fami …
There is currently a relative paucity of information to guide advice given to and the clinical management of these individuals. Much …
874 results